NEW YORK (PRWEB)
December 21, 2022
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Montreal for 2022. Montreal is one of the east coast’s leading life sciences regions and has seen a boom in the sector recently thanks in part to a large talent pool, driven by its eight universities and three engineering schools, and significant private and public funding for research and innovation. The leaders on this year’s list and their companies have made the most of this prime location, developing revolutionary solutions across a range of specialties from proteomics to immunology, cannabis, consumer medical devices, and imaging software, among many others.
Some of the distinguished leaders on this year’s list include CEO of Medicom Group Guillaume Laverdure, who led his company’s transformation to masks and N95 respirators and oversaw the opening of six new personal protective equipment production facilities on three continents during the COVID-19 pandemic. Meanwhile, Co-Founder and CEO Eric Simoneau’s Motion Composites has developed innovative, award-winning high-performance manual wheelchairs that provide users with enhanced mobility and unparalleled quality. And Valeo Pharma’s CEO, Steve Saviuk, has transformed his company from its early years as an in-licensor of established brands to a fast-growing, full-service Canadian pharmaceutical company.
The leadership positions held by this year’s awardees run the gamut, from CEO and COO to CFO, CTO, and SVP. What they have in common is their demonstrated commitment to improving the lives of patients in the Montreal area and beyond through the innovation of unparalleled technologies in the healthcare space. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Montreal for 2022.
Martin LeBlanc (CellCarta), Guillaume Laverdure (Medicom Group), Lloyd Segal (Repare Therapeutics), Michel Dulong (Dulong Medtech), Idriss Saiah (Immuni T), Nicholas Sosiak (Cannara Biotech), Eric Simoneau (Motion Composites), Steve Saviuk (Valeo Pharma), Bruno Mäder (JAMP Pharma Group), Paul Fenton (Montrium), Sylvie Pelletier (Bio-K+ International), Rene Rebeaud (Hermes Medical Solutions), Tevin Pathareddy (Montrium), Dr. Horst Zerbe (IntelGenx), Jean-Francois Roy (Hexoskin), Alexandre Fuentes (Emovi), Yvan Cote (Neopharm Labs), Michael Laranjo (Otsuka Canada Pharmaceutical Inc.), George Ambartsoumian (GA International Inc.), Iain Boomer (The PMCQ), Frederic Fasano (Valeo Pharma), Jeffrey Albert (X-Chem), Philippe Dubuc (Theratechnologies), Michel Sirgent (Bio-K+ International), Dominic Begin (Organon Canada).
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.
Share article on social media or email: